Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Laptop in, paper out
2013-07-31

 

Prof Pieter Nel gives advice to students.
Photo: Johan Roux
31 July 2013

The first major steps to a paperless lecture environment for the School of Medicine were taken in July 2013 with the presentation of laptops to all first-year- medical students.

The aim is to have the entire undergraduate medical programme computer-driven within a few years and to get rid of paper in the classroom.

Prof Pieter Nel, Programme Director: Health Sciences at the school in the Faculty of Health Sciences, said, “As far as we know, this action is the first of its kind in any medical school in South Africa whereby an entire class are supplied with computers for this purpose. We also have no knowledge of anything similar in any programme within any other faculty at any university in South Africa.”

All first-year medical students received laptops. The UFS is facilitating the process to provide students with computer access via their own laptops. “The reason for this is that the undergraduate health-sciences programme will be totally computerised from now on. Students will therefore utilise their laptops in all their contact sessions.”

The entire building where teaching takes place is equipped with Wi-Fi. The students buy the laptops at a much lower cost than the commercial price.

Prof Nel said the printing costs of study material during a student’s undergraduate study years can amount to as much as R5 000.

In future, first-year students will receive laptops, computerising the entire undergraduate health-sciences programme within a few years, Prof Nel said.

During the presentation of the first laptops, Prof Gert van Zyl, Dean of the Faculty of Health Sciences, referred to this action as a big step forward in modernising the undergraduate training of medical students in the faculty.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept